We are pleased to announce the launch this month of a new sister journal to Bladder Cancer – introducing: Kidney Cancer. Find out more at the journal website, where the inaugural issue is openly available.

Investigating the impact of the proliferation biomarker Ki-67 in initial stage pTa urothelial carcinoma of the bladder. Examples of low (<10%, A) and strong (≥50%, B) staining of Ki-67 under 5 fold and 40 fold magnification. From: Breyer, et al., Bladder Cancer, vol. 3, no. 3, pp. 173-180, 2017

The synergistic relationship between immunotherapy and radiation.
From Buchwald and Efstathiou. Bladder Cancer, vol. 1, no. 1, pp. 15-27, 2015

Pathologic substaging – pT1c denotes tumor invasion below the muscularis mucosae but above the muscularis propria.
From: Gershman et al., Bladder Cancer, vol. 2, no. 1, pp. 1-14, 2016

Generating the muscle invasive bladder cancer interactome.
From: Bhat et al., Bladder Cancer, vol. 2, no. 1, pp. 65-76, 2016

Expression status of hypoxia related markers in bladder cancer tissue.  Immunohistochemistry staining of HIF1a, CA-IX, GLUT-1 and Ki-67 in paraffin-embedded TMA sections of bladder cancer tissues. 
From: Boström et al., Bladder Cancer, vol. 2, no. 1, pp. 101-109, 2016